These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2975810)

  • 21. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
    Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
    Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L; Panksepp J
    Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quipazine-induced behavior in neonatal rat pups.
    Spear LP; Ristine LA
    Pharmacol Biochem Behav; 1981 Jun; 14(6):831-4. PubMed ID: 7255519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin and feeding responses of rats to amino acid imbalance: initial phase.
    Gietzen DW; Rogers QR; Leung PM; Semon B; Piechota T
    Am J Physiol; 1987 Nov; 253(5 Pt 2):R763-71. PubMed ID: 2446514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO; Johnson MD; Crowley WR
    Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin antagonist pirenperone inhibits sexual behavior in the male rat: attenuation by quipazine.
    Mendelson SD; Gorzalka BB
    Pharmacol Biochem Behav; 1985 Apr; 22(4):565-71. PubMed ID: 3158005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined effect of quipazine and haloperidol on plasma prolactin release.
    Feigenbaum J; Yanai J; Klawans HL; Chatterton R
    Int J Neurosci; 1983; 18(1-2):37-40. PubMed ID: 6840980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of metergoline and quipazine on locomotor activity of rats in novel and familiar environments.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 May; 20(5):701-5. PubMed ID: 6739514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of quipazine and D-fenfluramine, two serotonin-like drugs, on TSH secretion in basal and cold stimulated conditions in the rat.
    Di Renzo GF; Quattrone A; Schettini G; Preziosi P
    Life Sci; 1978 Jun; 22(21):1879-85. PubMed ID: 672433
    [No Abstract]   [Full Text] [Related]  

  • 33. Brain serotonergic neurons: their role in a form of dominance-subordination behavior in rats.
    Kostowski W; Plewako M; Bidzinski A
    Physiol Behav; 1984 Sep; 33(3):365-71. PubMed ID: 6096901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced activation of the inferior olivary nucleus in young rabbits. Differential effects of harmaline and quipazine.
    Barragan LA; Delhaye-Bouchaud N; Laget P
    Neuropharmacology; 1985 Jul; 24(7):645-54. PubMed ID: 3160966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of serotonergic influence on apomorphine-induced stereotypy.
    Rotrosen J; Angrist BM; Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Oct; 20(1):133-5. PubMed ID: 4264265
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonergic involvement in neuroendocrine function.
    Schettini G; Quattrone A; Di Renzo G; Preziosi P
    Pharmacol Res Commun; 1980 Mar; 12(3):249-54. PubMed ID: 6446722
    [No Abstract]   [Full Text] [Related]  

  • 40. Sensitivity to psychoactive drugs and the serotonergic neuronal system.
    Appel JB; Joseph JA; Utsey E; Hernandey LL
    Commun Psychopharmacol; 1977; 1(6):541-51. PubMed ID: 147154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.